BioLife Solutions Inc (BLFS)
22.55
-0.44%
BioLife Solutions Inc (BLFS) is currently trading at $22.55. This represents a loss of 0.44% from the previous session. With a market capitalization of $1.09B, BLFS is a key component of the Health Care sector. Investors looking to trade BLFS should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade BLFS commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, BioLife Solutions Inc (BLFS) shows a bearish trend. Analysts are watching the 22.95 level closely.
Fundamentals
Mkt Cap1.09B
P/E Ratio0.0000
Volume162,495
60-Day Technical Chart
Advanced Charting
Need more indicators for BLFS? Use the world's #1 platform.
Open BLFS on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $23
| Metric |
BLFS -0.44% |
BMNR +13.22% |
HL +1.04% |
USAR +0.29% |
|---|---|---|---|---|
| Price | $22.55 | $21.99 | $23.86 | $20.45 |
| Mkt Cap | $1.09B | $9.99B | $15.99B | $4.46B |
| - | View → | View → | View → |
Latest Headlines
A Look At BioLife Solutions (BLFS) Valuation After New Qkine Cell And Gene Therapy Partnership
simplywall.st • Feb 24, 2026
Trading the Move, Not the Narrative: (BLFS) Edition
Stock Traders Daily • Feb 23, 2026
BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market
PR Newswire • Feb 12, 2026
BioLife Solutions, Inc. (BLFS) Surpasses Q3 Earnings and Revenue Estimates
Yahoo Finance • Nov 6, 2025
BioLife Solutions (NASDAQ: BLFS) outlines 2025 investor conference schedule and IR deck
Stock Titan • Nov 17, 2025
● Gemini Agentic AI Analyst Insight for BLFS
Market Education
- These Whales are taking all the Ape money - aka Large Fund Mgmt Companies Jul 17, 2023
- Long Short Strategy to Manage Risk May 31, 2024
- Fails to Deliver DeMystified May 31, 2024
External Research